<?xml version="1.0" encoding="UTF-8"?><TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://publications.europa.eu/resource/schema/ted/R2.0.9/publication" xmlns:n2016="http://publications.europa.eu/resource/schema/ted/2016/nuts" xsi:schemaLocation="http://publications.europa.eu/resource/schema/ted/R2.0.9/publication TED_EXPORT.xsd" VERSION="R2.0.9.S03.E01" DOC_ID="449711-2020" EDITION="2020187"><TECHNICAL_SECTION><RECEPTION_ID>20-463702-001</RECEPTION_ID><DELETION_DATE>20201230</DELETION_DATE><FORM_LG_LIST>EN </FORM_LG_LIST><COMMENTS>From Convertor</COMMENTS></TECHNICAL_SECTION><LINKS_SECTION><XML_SCHEMA_DEFINITION_LINK xlink:type="simple" xlink:href="http://ted.europa.eu" xlink:title="TED WEBSITE"/><OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/></LINKS_SECTION><CODED_DATA_SECTION><REF_OJS><COLL_OJ>S</COLL_OJ><NO_OJ>187</NO_OJ><DATE_PUB>20200925</DATE_PUB></REF_OJS><NOTICE_DATA><NO_DOC_OJS>2020/S 187-449711</NO_DOC_OJS><URI_LIST><URI_DOC LG="EN">http://ted.europa.eu/udl?uri=TED:NOTICE:449711-2020:TEXT:EN:HTML</URI_DOC></URI_LIST><LG_ORIG>EN</LG_ORIG><ISO_COUNTRY VALUE="IE"/><IA_URL_GENERAL>http://www.beaumont.ie</IA_URL_GENERAL><ORIGINAL_CPV CODE="33696500">Laboratory reagents</ORIGINAL_CPV><ORIGINAL_CPV CODE="33124130">Diagnostic supplies</ORIGINAL_CPV><ORIGINAL_CPV CODE="33141625">Diagnostic kits</ORIGINAL_CPV><ORIGINAL_CPV CODE="33694000">Diagnostic agents</ORIGINAL_CPV><ORIGINAL_CPV CODE="33696000">Reagents and contrast media</ORIGINAL_CPV><ORIGINAL_CPV CODE="33696100">Blood-grouping reagents</ORIGINAL_CPV><ORIGINAL_CPV CODE="33696200">Blood-testing reagents</ORIGINAL_CPV><n2016:PERFORMANCE_NUTS CODE="IE061">Dublin</n2016:PERFORMANCE_NUTS><n2016:CA_CE_NUTS CODE="IE061">Dublin</n2016:CA_CE_NUTS><n2016:TENDERER_NUTS CODE="UKC22">Tyneside</n2016:TENDERER_NUTS><n2016:TENDERER_NUTS CODE="UKG32">Solihull</n2016:TENDERER_NUTS><VALUES><VALUE TYPE="PROCUREMENT_TOTAL" CURRENCY="EUR">5000000.00</VALUE></VALUES><REF_NOTICE><NO_DOC_OJS>2019/S 167-408105</NO_DOC_OJS></REF_NOTICE></NOTICE_DATA><CODIF_DATA><DS_DATE_DISPATCH>20200921</DS_DATE_DISPATCH><AA_AUTHORITY_TYPE CODE="6">Body governed by public law</AA_AUTHORITY_TYPE><TD_DOCUMENT_TYPE CODE="7">Contract award notice</TD_DOCUMENT_TYPE><NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE><PR_PROC CODE="1">Open procedure</PR_PROC><RP_REGULATION CODE="5">European Union, with participation by GPA countries</RP_REGULATION><TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID><AC_AWARD_CRIT CODE="2">The most economic tender</AC_AWARD_CRIT><MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES><HEADING>01B03</HEADING><INITIATOR>01</INITIATOR></CODIF_DATA></CODED_DATA_SECTION><TRANSLATION_SECTION><ML_TITLES><ML_TI_DOC LG="BG"><TI_CY>Иpлaндия</TI_CY><TI_TOWN>Дъблин</TI_TOWN><TI_TEXT><P>Лабораторни реактиви</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="CS"><TI_CY>Irsko</TI_CY><TI_TOWN>Dublin</TI_TOWN><TI_TEXT><P>Laboratorní činidla</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DA"><TI_CY>Irland</TI_CY><TI_TOWN>Dublin</TI_TOWN><TI_TEXT><P>Laboratoriereagenser</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DE"><TI_CY>Irland</TI_CY><TI_TOWN>Dublin</TI_TOWN><TI_TEXT><P>Laborreagenzien</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EL"><TI_CY>Ιρλανδία</TI_CY><TI_TOWN>Δουβλίνο</TI_TOWN><TI_TEXT><P>Αντιδραστήρια εργαστηρίων</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EN"><TI_CY>Ireland</TI_CY><TI_TOWN>Dublin</TI_TOWN><TI_TEXT><P>Laboratory reagents</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ES"><TI_CY>Irlanda</TI_CY><TI_TOWN>Dublín</TI_TOWN><TI_TEXT><P>Reactivos de laboratorio</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ET"><TI_CY>Iirimaa</TI_CY><TI_TOWN>Dublin</TI_TOWN><TI_TEXT><P>Laboratooriumireaktiivid</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FI"><TI_CY>Irlanti</TI_CY><TI_TOWN>Dublin</TI_TOWN><TI_TEXT><P>Laboratorioreagenssit</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FR"><TI_CY>Irlande</TI_CY><TI_TOWN>Dublin</TI_TOWN><TI_TEXT><P>Réactifs de laboratoire</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="GA"><TI_CY>Éire</TI_CY><TI_TOWN>Baile Átha Cliath</TI_TOWN><TI_TEXT><P>Laboratory reagents</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HR"><TI_CY>Irska</TI_CY><TI_TOWN>Dublin</TI_TOWN><TI_TEXT><P>Laboratorijski reagensi</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HU"><TI_CY>Írország</TI_CY><TI_TOWN>Dublin</TI_TOWN><TI_TEXT><P>Laboratóriumi reagensek</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="IT"><TI_CY>Irlanda</TI_CY><TI_TOWN>Dublino</TI_TOWN><TI_TEXT><P>Reattivi per laboratorio</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LT"><TI_CY>Airija</TI_CY><TI_TOWN>Dublinas</TI_TOWN><TI_TEXT><P>Laboratoriniai reagentai</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LV"><TI_CY>Īrija</TI_CY><TI_TOWN>Dublina</TI_TOWN><TI_TEXT><P>Laboratorijas reaģenti</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="MT"><TI_CY>l-Irlanda</TI_CY><TI_TOWN>Dublin</TI_TOWN><TI_TEXT><P>Reaġenti tal-laboratorju</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="NL"><TI_CY>Ierland</TI_CY><TI_TOWN>Dublin</TI_TOWN><TI_TEXT><P>Laboratoriumreagentia</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PL"><TI_CY>Irlandia</TI_CY><TI_TOWN>Dublin</TI_TOWN><TI_TEXT><P>Odczynniki laboratoryjne</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PT"><TI_CY>Irlanda</TI_CY><TI_TOWN>Dublim</TI_TOWN><TI_TEXT><P>Reagentes de laboratório</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="RO"><TI_CY>Irlanda</TI_CY><TI_TOWN>Dublin</TI_TOWN><TI_TEXT><P>Reactivi de laborator</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SK"><TI_CY>Írsko</TI_CY><TI_TOWN>Dublin</TI_TOWN><TI_TEXT><P>Laboratórne činidlá</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SL"><TI_CY>Irska</TI_CY><TI_TOWN>Dublin</TI_TOWN><TI_TEXT><P>Laboratorijski reagenti</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SV"><TI_CY>Irland</TI_CY><TI_TOWN>Dublin</TI_TOWN><TI_TEXT><P>Laboratoriereagenser</P></TI_TEXT></ML_TI_DOC></ML_TITLES><ML_AA_NAMES><AA_NAME LG="EN">Beaumont Hospital</AA_NAME></ML_AA_NAMES></TRANSLATION_SECTION><FORM_SECTION><NOTICE_UUID>84418d75-0909-4689-95e9-d5f917ecbb70</NOTICE_UUID><F03_2014 CATEGORY="ORIGINAL" FORM="F03" LG="EN"><LEGAL_BASIS VALUE="32014L0024"/><CONTRACTING_BODY><ADDRESS_CONTRACTING_BODY><OFFICIALNAME>Beaumont Hospital</OFFICIALNAME><NATIONALID>N/A</NATIONALID><ADDRESS>Beaumont Road, Beaumont</ADDRESS><TOWN>Dublin</TOWN><COUNTRY VALUE="IE"/><CONTACT_POINT>Greg O'Leary</CONTACT_POINT><PHONE>+353 18092658</PHONE><E_MAIL>tendering@beaumont.ie</E_MAIL><n2016:NUTS CODE="IE061"/><URL_GENERAL>http://www.beaumont.ie</URL_GENERAL><URL_BUYER>https://irl.eu-supply.com/ctm/Company/CompanyInformation/Index/403</URL_BUYER></ADDRESS_CONTRACTING_BODY><CA_TYPE VALUE="BODY_PUBLIC"/><CA_ACTIVITY VALUE="HEALTH"/></CONTRACTING_BODY><OBJECT_CONTRACT><TITLE><P>Multi-party Framework Agreement for the Supply of Single Antigen Solid Phase HLA Antibody Screening Kits</P></TITLE><REFERENCE_NUMBER>2714</REFERENCE_NUMBER><CPV_MAIN><CPV_CODE CODE="33696500"/></CPV_MAIN><TYPE_CONTRACT CTYPE="SUPPLIES"/><SHORT_DESCR><P>The National Histocompatibility and Immunogenetics Service for Solid Organ Transplantation at Beaumont Hospital (‘NHISSOT’) provides a HLA typing and antibody screening service for the five solid organ transplant programmes in the Republic of Ireland. At any given time, the service has approximately 650 patients on waiting lists. The service also performs a post-transplant HLA antibody monitoring service. The contracting authority intends to establish a multi-party framework agreement for the supply of single antigen solid phase HLA antibody screening kits.</P></SHORT_DESCR><VAL_TOTAL CURRENCY="EUR">5000000.00</VAL_TOTAL><NO_LOT_DIVISION/><OBJECT_DESCR ITEM="1"><CPV_ADDITIONAL><CPV_CODE CODE="33124130"/></CPV_ADDITIONAL><CPV_ADDITIONAL><CPV_CODE CODE="33141625"/></CPV_ADDITIONAL><CPV_ADDITIONAL><CPV_CODE CODE="33694000"/></CPV_ADDITIONAL><CPV_ADDITIONAL><CPV_CODE CODE="33696000"/></CPV_ADDITIONAL><CPV_ADDITIONAL><CPV_CODE CODE="33696100"/></CPV_ADDITIONAL><CPV_ADDITIONAL><CPV_CODE CODE="33696200"/></CPV_ADDITIONAL><n2016:NUTS CODE="IE061"/><MAIN_SITE><P>Dublin 9.</P></MAIN_SITE><SHORT_DESCR><P>The National Histocompatibility and Immunogenetics Service for Solid Organ Transplantation at Beaumont Hospital (‘NHISSOT’) provides a HLA typing and antibody screening service for the five solid organ transplant programmes in the Republic of Ireland. At any given time, the service has approximately 650 patients on waiting lists. The service also performs a post-transplant HLA antibody monitoring service. The contracting authority intends to establish a multi-party framework agreement for the supply of single antigen solid phase HLA antibody screening kits.</P></SHORT_DESCR><AC><AC_QUALITY><AC_CRITERION>Quality of products offered</AC_CRITERION><AC_WEIGHTING>40 %</AC_WEIGHTING></AC_QUALITY><AC_QUALITY><AC_CRITERION>Support and service</AC_CRITERION><AC_WEIGHTING>10 %</AC_WEIGHTING></AC_QUALITY><AC_QUALITY><AC_CRITERION>Merit of additional items</AC_CRITERION><AC_WEIGHTING>10 %</AC_WEIGHTING></AC_QUALITY><AC_COST><AC_CRITERION>Ultimate cost</AC_CRITERION><AC_WEIGHTING>40 %</AC_WEIGHTING></AC_COST></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/><INFO_ADD><P>Please consult the invitation to tender documentation, available to download from www.etenders.gov.ie</P></INFO_ADD></OBJECT_DESCR></OBJECT_CONTRACT><PROCEDURE><PT_OPEN/><ACCELERATED_PROC><P>In accordance with Article 27.3 of Directive 2014/24/EU, the contracting authority is availing of shortened timescales in respect of this competition. The urgency associated with this requirement arises from the fact that the required products will be used in an acute hospital setting. On grounds of patient care, time is of the essence in respect of this competition.</P></ACCELERATED_PROC><FRAMEWORK/><CONTRACT_COVERED_GPA/><NOTICE_NUMBER_OJ>2019/S 167-408105</NOTICE_NUMBER_OJ></PROCEDURE><AWARD_CONTRACT ITEM="1"><CONTRACT_NO>1</CONTRACT_NO><TITLE><P>Multi-party Framework Agreement for the Supply of Single Antigen Solid Phase HLA Antibody Screening Kits</P></TITLE><AWARDED_CONTRACT><DATE_CONCLUSION_CONTRACT>2020-02-27</DATE_CONCLUSION_CONTRACT><TENDERS><NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED><NB_TENDERS_RECEIVED_SME>2</NB_TENDERS_RECEIVED_SME><NB_TENDERS_RECEIVED_OTHER_EU>2</NB_TENDERS_RECEIVED_OTHER_EU><NB_TENDERS_RECEIVED_NON_EU>0</NB_TENDERS_RECEIVED_NON_EU><NB_TENDERS_RECEIVED_EMEANS>2</NB_TENDERS_RECEIVED_EMEANS></TENDERS><CONTRACTORS><NO_AWARDED_TO_GROUP/><CONTRACTOR><ADDRESS_CONTRACTOR><OFFICIALNAME>V.H. Bio Ltd</OFFICIALNAME><TOWN>Gateshead</TOWN><COUNTRY VALUE="UK"/><n2016:NUTS CODE="UKC22"/></ADDRESS_CONTRACTOR><NO_SME/></CONTRACTOR></CONTRACTORS><VALUES><VAL_ESTIMATED_TOTAL CURRENCY="EUR">2000000.00</VAL_ESTIMATED_TOTAL><VAL_TOTAL CURRENCY="EUR">2000000.00</VAL_TOTAL></VALUES></AWARDED_CONTRACT></AWARD_CONTRACT><AWARD_CONTRACT ITEM="2"><CONTRACT_NO>2</CONTRACT_NO><TITLE><P>Multi-party Framework Agreement for the Supply of Single Antigen Solid Phase HLA Antibody Screening Kits</P></TITLE><AWARDED_CONTRACT><DATE_CONCLUSION_CONTRACT>2020-02-27</DATE_CONCLUSION_CONTRACT><TENDERS><NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED><NB_TENDERS_RECEIVED_SME>2</NB_TENDERS_RECEIVED_SME><NB_TENDERS_RECEIVED_OTHER_EU>2</NB_TENDERS_RECEIVED_OTHER_EU><NB_TENDERS_RECEIVED_NON_EU>0</NB_TENDERS_RECEIVED_NON_EU><NB_TENDERS_RECEIVED_EMEANS>2</NB_TENDERS_RECEIVED_EMEANS></TENDERS><CONTRACTORS><NO_AWARDED_TO_GROUP/><CONTRACTOR><ADDRESS_CONTRACTOR><OFFICIALNAME>IBG Immucor Ltd</OFFICIALNAME><TOWN>Solihull</TOWN><COUNTRY VALUE="UK"/><n2016:NUTS CODE="UKG32"/></ADDRESS_CONTRACTOR><SME/></CONTRACTOR></CONTRACTORS><VALUES><VAL_ESTIMATED_TOTAL CURRENCY="EUR">2000000.00</VAL_ESTIMATED_TOTAL><VAL_TOTAL CURRENCY="EUR">2000000.00</VAL_TOTAL></VALUES></AWARDED_CONTRACT></AWARD_CONTRACT><COMPLEMENTARY_INFO><INFO_ADD><P>Please Consult the Invitation to Tender Document, Available to Download from www.etenders.gov.ie</P></INFO_ADD><ADDRESS_REVIEW_BODY><OFFICIALNAME>The High Court</OFFICIALNAME><ADDRESS>Central office of the High Court, Ground Floor, East Wing, The Four Courts, Inns Quay</ADDRESS><TOWN>Dublin 7</TOWN><COUNTRY VALUE="IE"/><PHONE>+353 18886000</PHONE><E_MAIL>HighCourtCentralOffice@courts.ie</E_MAIL><URL>http://www.courts.ie</URL></ADDRESS_REVIEW_BODY><REVIEW_PROCEDURE><P>The contracting authority undertakes that this framework agreement shall not be established until a period of 14 calendar days has elapsed, commencing on the day after the date of electronic notification of all concerned tenderers. This ‘standstill period’ is being observed in accordance with the provisions of S.I. 130 of 2010.</P></REVIEW_PROCEDURE><DATE_DISPATCH_NOTICE>2020-09-21</DATE_DISPATCH_NOTICE></COMPLEMENTARY_INFO></F03_2014></FORM_SECTION></TED_EXPORT>